Privi Speciality Chemicals Ltd — Q1 FY27 earnings call
Summary generated by AI from the official transcript Privi Speciality Chemicals Ltd filed with BSE on 03 Aug 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Privi Speciality Chemicals reported Q1 FY27 revenue of Rs. 666 crore, up 19.22% year-on-year, with EBITDA of Rs. 167.47 crores and EBITDA margin of 24.58%. Management attributed growth to a mix of volume, price increases and improved product mix, while gross margin compressed due to a normalization from the prior year's low-cost raw material advantage. The company also filed its scheme with the NCLT for the proposed merger of Privi Speciality Chemicals, Privi Fine Sciences and Privi Biotechnologies, and discussed progress on Phase-1 and Phase-2 capacity expansions.
1 statement from this call is not shown because its supporting quote could not be reproduced within our quoting limits. Nothing shown here is affected: every statement on this page carries its verified quote.
Numbers mentioned
Revenue: Rs. 666 crore (Q1 FY27)
p. 3
“During the quarter, company reported revenue of Rs. 666 crore, which is reflecting growth of 19.22% year-on-year, supported by healthy demand across both domestic and international markets.”
Sanjeev Patil, page 3 of the filed PDF · View the filing
Total income (consolidated): Rs. 681.42 crores (Q1 FY27)
p. 5
“The total income that was achieved on a consolidated basis for the quarter was around Rs. 681.42 crores, which indicates a growth of 20.01% on a year-on-year basis.”
Narayan S. Iyer, page 5 of the filed PDF · View the filing
EBITDA: Rs. 167.47 crores (Q1 FY27)
p. 5
“The EBITDA achieved during the same period was Rs. 167.47 crores, registering a growth of 18.73% on a year-on-year basis.”
Narayan S. Iyer, page 5 of the filed PDF · View the filing
EBITDA margin: 24.58% (Q1 FY27)
p. 5
“EBITDA margins were at around 24.58% for the quarter, and we expect, as mentioned, EBITDA margins to be almost similar in the near future.”
Narayan S. Iyer, page 5 of the filed PDF · View the filing
Profit after tax: Rs. 83.2 crores (Q1 FY27)
p. 5
“Profit after tax for the quarter was around Rs. 83.2 crores as against Rs. 61.46 crores achieved in Q1 FY26”
Narayan S. Iyer, page 5 of the filed PDF · View the filing
Working capital cycle: 108 days (Q1 FY27)
p. 6
“we have been able to bring down our overall working capital cycle in this quarter to 108 days during the period as against 141 dats in the previous year”
Narayan S. Iyer, page 6 of the filed PDF · View the filing
Net debt: Rs. 865 crores (as on June 2026)
p. 6
“Our net debt as on June ‘26 was Rs. 865 crores, this is net of cash and surplus money deployed in mutual funds, with a net debt-to-EBITDA ratio of 1.29, reflecting our focus on maintaining financial flexibility while supporting growth investments.”
Narayan S. Iyer, page 6 of the filed PDF · View the filing
Net debt-to-equity ratio: 0.57x (as on June 2026)
p. 6
“Our net debt-to-equity ratio was a very sound healthy 0.57x, reflecting good generation of profit.”
Narayan S. Iyer, page 6 of the filed PDF · View the filing
ROE: 21.7% (Q1 FY27)
p. 6
“Our ROE and ROCE achieved during the quarter was 21.7% and 22.72% respectively.”
Narayan S. Iyer, page 6 of the filed PDF · View the filing
PRIGIV JV revenue: Rs. 18 crores (Q1 FY27)
p. 9
“The PRIGIV JV revenue generated was about Rs. 18 crores and EBITDA generated was about 14%-15%.”
Narayan S. Iyer, page 9 of the filed PDF · View the filing
Crude-based raw materials: 15% to 18% of purchases
p. 14
“Crude-based raw material forms about close to 15% to 18% of the overall purchases that we do.”
Narayan S. Iyer, page 14 of the filed PDF · View the filing
Camphor as % of revenue: 5% to 6%
p. 11
“It is about 5% to 6% of our total revenue.”
Sanjeev Patil, page 11 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Revenue and EBITDA vision — Rs. 5,000 crores in revenue and Rs. 1,000 crores plus of EBITDA · next three to four years
stated as an aspiration by Narayan S. Iyer
p. 6
“the vision of Rs. 5,000 crores in revenue and Rs. 1,000 crores plus of EBITDA over the next three to four years, representing a growth of about 2x”
Narayan S. Iyer, page 6 of the filed PDF · View the filing
EBITDA margin — 20%+ · near future and coming years
stated firmly by Narayan S. Iyer
p. 5
“The EBITDA margins are expected to sustain at a (+20%) driven by the operational efficiencies and improved product mix and increased capacities going to come forward in the near future and in the coming years.”
Narayan S. Iyer, page 5 of the filed PDF · View the filing
Production capacity (Phase-1) — 54,000 metric tons · shortly / next 15 days
stated firmly by Sanjeev Patil
p. 7
“the current flagship product expansion will happen in the course of the next 15 days or so. So from 48,000 metric tons, as Narayan said in his opening remarks, from 48,000 metric tons we will go to 54,000 metric tons.”
Sanjeev Patil, page 7 of the filed PDF · View the filing
Production capacity (Phase-2) — 66,000 metric tons · September 2027
stated firmly by Narayan S. Iyer
p. 8
“the balance 12,000 metric tons with regard to the Phase-2 CAPEX, that is what we are trying to say that by September 2027, the Phase-2 will be completed.”
Narayan S. Iyer, page 8 of the filed PDF · View the filing
CAGR and EBITDA margin — 20% CAGR
stated firmly by Mahesh Babani
p. 8
“We are confident of achieving 20%, maintaining 20% CAGR with similar EBITDA margins.”
Mahesh Babani, page 8 of the filed PDF · View the filing
Merger completion — completion of merger of Privi Speciality, Privi Fine Sciences and Privi Biotechnologies · this financial year
stated firmly by Narayan S. Iyer
p. 5
“We expect the merger to be completed in this financial year.”
Narayan S. Iyer, page 5 of the filed PDF · View the filing
CAPEX — Rs. 850 crores to Rs. 900 crores · this year and following two years
stated conditionally by Narayan S. Iyer
p. 14
“The broad outline for this year and following two years, it could be around in the range of Rs. 850 crores to Rs. 900 crores or so.”
Narayan S. Iyer, page 14 of the filed PDF · View the filing
New specialty molecule plants contribution — contributions from new plants toward 5K, 1K plan · H2 of next financial year
stated conditionally by Sanjeev Patil
p. 14
“We are expecting that by about middle of next year, they would be mechanically completed. And we expect that H2 of next financial year, we should start getting contributions from these plants”
Sanjeev Patil, page 14 of the filed PDF · View the filing
Bio-based commercial plant decision — large-scale plant decision after pilot study · 12 to 15 months for demonstration plant plus a year of study
stated conditionally by Sanjeev Patil
p. 8
“this is something that would happen probably after we put up the plant, which will take about 12 months to 15 months. And once it is commissioned, we will probably run it for a year to study all the nuances of manufacturing. And then we will go for the large-scale plant.”
Sanjeev Patil, page 8 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said last year benefited from low-cost raw material and high selling prices, and RMC as % of sales is expected to normalize to 52-55%, with EBITDA margin maintained near 25%.
Answered by Narayan S. Iyer
Asked by Vivek Rakholiya: What drove the gross margin compression and how much will recover over FY27; will growth be back-ended to H2?
p. 7
“we had also mentioned that the RMC percentage on the sales will be between the range of 52% to 55%”
Narayan S. Iyer, page 7 of the filed PDF · View the filing
Management clarified Phase-2 completion is targeted for September 2027 and reaffirmed no change in the 5K, 1K guidance.
Answered by Narayan S. Iyer
Asked by Vivek Rakholiya: Is the Phase-2 capacity expansion date June 2027 or September 2027, and will guidance be revised?
p. 8
“the balance 12,000 metric tons with regard to the Phase-2 CAPEX, that is what we are trying to say that by September 2027, the Phase-2 will be completed.”
Narayan S. Iyer, page 8 of the filed PDF · View the filing
Management said they are building a 2 tons/day demonstration plant in Navi Mumbai and will study manufacturing for about a year before scaling up.
Answered by Sanjeev Patil
Asked by Vivek Rakholiya: What metrics will determine the bio-based pilot plant's move to commercial scale?
p. 8
“we will be putting up 2 tons per day pilot plant, which will produce all the molecules that we are looking at.”
Sanjeev Patil, page 8 of the filed PDF · View the filing
Management disclosed PRIGIV generated about Rs. 18 crores in revenue with 14-15% EBITDA margin.
Answered by Narayan S. Iyer
Asked by Nirav Gandhi: What was the PRIGIV JV revenue and EBITDA contribution in Q1?
p. 9
“The PRIGIV JV revenue generated was about Rs. 18 crores and EBITDA generated was about 14%-15%.”
Narayan S. Iyer, page 9 of the filed PDF · View the filing
Management said camphor is a small part of revenue and largely made via a different route than competitors, so it does not much affect them.
Answered by Sanjeev Patil
Asked by Anisha Dalal: What is driving the camphor market demand-supply mismatch and its impact on the company?
p. 11
“It is about 5% to 6% of our total revenue. So, we bother up to a point only.”
Sanjeev Patil, page 11 of the filed PDF · View the filing
Management said there was minimal impact since their raw materials are predominantly non-crude.
Answered by Narayan S. Iyer
Asked by Rajesh Mishra: What impact has the Iran war had on raw material prices and profitability?
p. 11
“predominantly, it is non-crude items that we manufacture. So, really, we have not been impacted because of the war that has been going around.”
Narayan S. Iyer, page 11 of the filed PDF · View the filing
Management said about 6,000 metric tons would be added post-merger.
Answered by Narayan S. Iyer
Asked by Krish Talot: What additional capacity would come from the merger with Privi Fine Sciences?
p. 12
“It is close to about 6,000 metric tons that get added to the Privi portfolio.”
Narayan S. Iyer, page 12 of the filed PDF · View the filing
Management said crude-based raw materials are 15-18% of purchases, with CAPEX planned at Rs. 850-900 crores.
Answered by Narayan S. Iyer
Asked by Suraj Shinde: What percentage of raw materials are crude-based and what CAPEX is planned for the next two years?
p. 14
“Crude-based raw material forms about close to 15% to 18% of the overall purchases that we do.”
Narayan S. Iyer, page 14 of the filed PDF · View the filing
Management said Maltol/Ethyl Maltol are currently 95% made in China, presenting a China-plus-one opportunity, with the company aiming to be the only fully backward-integrated producer from corn cob.
Answered by Sanjeev Patil
Asked by Midhun James: What is the market opportunity and customer base for Maltol and Musk T?
p. 15
“Maltol and Ethyl Maltol, both are right now made, I would say, over 95% is manufactured only in China.”
Sanjeev Patil, page 15 of the filed PDF · View the filing
Management said they have been managing the Red Sea impact for years and see no margin impact currently.
Answered by Narayan S. Iyer
Asked by Niket Jadhav: Are freight costs increasing due to the Red Sea/Houthi crisis?
p. 16
“Red Sea impact now has been for quite a number of years. And we have been sailing through that impact now.”
Narayan S. Iyer, page 16 of the filed PDF · View the filing
Risks flagged
Volatility in Alpha-pinene and raw material pricing
p. 9
“But no one can actually predict alpha pining prices.”
Sanjeev Patil, page 9 of the filed PDF · View the filing
Input cost volatility during the quarter
p. 6
“While input costs remain volatile during the quarter, we continue to focus on operational efficiencies, cost optimization initiatives and improved capacity utilization which supported margin resilience.”
Narayan S. Iyer, page 6 of the filed PDF · View the filing
Possible weather-related delays to project execution
p. 7
“It could happen for a week or two, you may not have any activity if it rains too much.”
Sanjeev Patil, page 7 of the filed PDF · View the filing
Ongoing Red Sea shipping disruption affecting freight
p. 16
“Red Sea continues to be as it is.”
Narayan S. Iyer, page 16 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.